352 related articles for article (PubMed ID: 30109020)
1. Current overview and treatment of mantle cell lymphoma.
Schieber M; Gordon LI; Karmali R
F1000Res; 2018; 7():. PubMed ID: 30109020
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium Workshop.
Williams ME; Connors JM; Dreyling MH; Gascoyne RD; Kahl BS; Leonard JP; Press OW; Wilson WH
Leuk Lymphoma; 2011 Jan; 52(1):24-33. PubMed ID: 21133727
[TBL] [Abstract][Full Text] [Related]
3. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
Nastoupil LJ; Koff JL; Flowers CR
Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
[TBL] [Abstract][Full Text] [Related]
4. Mantle Cell Lymphoma: First-line Therapy in Patients Not Eligible for Stem Cell Transplantation.
Nazeef M; Kahl BS
Curr Treat Options Oncol; 2015 Jun; 16(6):29. PubMed ID: 25975443
[TBL] [Abstract][Full Text] [Related]
5. Recent advances and future directions in mantle cell lymphoma research: report of the 2016 mantle cell lymphoma consortium workshop.
Kahl BS; Dreyling M; Gordon LI; Quintanilla-Martinez L; Sotomayor EM
Leuk Lymphoma; 2017 Jul; 58(7):1561-1569. PubMed ID: 28140709
[TBL] [Abstract][Full Text] [Related]
6. Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents.
Inamdar AA; Goy A; Ayoub NM; Attia C; Oton L; Taruvai V; Costales M; Lin YT; Pecora A; Suh KS
Oncotarget; 2016 Jul; 7(30):48692-48731. PubMed ID: 27119356
[TBL] [Abstract][Full Text] [Related]
7. Recent advances and future directions in mantle cell lymphoma research: report of the 2018 mantle cell lymphoma consortium workshop.
Kahl BS; Dreyling M; Gordon LI; Martin P; Quintanilla-Martinez L; Sotomayor EM
Leuk Lymphoma; 2019 Aug; 60(8):1853-1865. PubMed ID: 30696305
[TBL] [Abstract][Full Text] [Related]
8. Refining the Mantle Cell Lymphoma Paradigm: Impact of Novel Therapies on Current Practice.
Avivi I; Goy A
Clin Cancer Res; 2015 Sep; 21(17):3853-61. PubMed ID: 26059189
[TBL] [Abstract][Full Text] [Related]
9. Current trials for frontline therapy of mantle cell lymphoma.
Steiner RE; Romaguera J; Wang M
J Hematol Oncol; 2018 Jan; 11(1):13. PubMed ID: 29374487
[TBL] [Abstract][Full Text] [Related]
10. Mantle cell lymphoma: biological insights and treatment advances.
Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: state of the art.
Skarbnik AP; Goy AH
Clin Adv Hematol Oncol; 2015 Jan; 13(1):44-55. PubMed ID: 25679973
[TBL] [Abstract][Full Text] [Related]
12. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL).
Dawar R; Hernandez-Ilizaliturri F
Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454
[TBL] [Abstract][Full Text] [Related]
13. Current Approaches to Mantle Cell Lymphoma: Diagnosis, Prognosis, and Therapies.
Cohen JB; Zain JM; Kahl BS
Am Soc Clin Oncol Educ Book; 2017; 37():512-525. PubMed ID: 28561694
[TBL] [Abstract][Full Text] [Related]
14. [Treatment for mantle cell lymphoma].
Izutsu K
Rinsho Ketsueki; 2017; 58(10):2026-2032. PubMed ID: 28978845
[TBL] [Abstract][Full Text] [Related]
15. Mantle cell lymphoma - Current standards of care and future directions.
Martin P; Ghione P; Dreyling M
Cancer Treat Rev; 2017 Jul; 58():51-60. PubMed ID: 28651117
[TBL] [Abstract][Full Text] [Related]
16. Current regimens and novel agents for mantle cell lymphoma.
Chen Y; Wang M; Romaguera J
Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in mantle cell lymphoma: report of the 2013 Mantle Cell Lymphoma Consortium Workshop.
Gordon LI; Bernstein SH; Jares P; Kahl BS; Witzig TE; Dreyling M
Leuk Lymphoma; 2014 Oct; 55(10):2262-70. PubMed ID: 24512319
[TBL] [Abstract][Full Text] [Related]
19. Confirmation of the mantle-cell lymphoma International Prognostic Index in randomized trials of the European Mantle-Cell Lymphoma Network.
Hoster E; Klapper W; Hermine O; Kluin-Nelemans HC; Walewski J; van Hoof A; Trneny M; Geisler CH; Di Raimondo F; Szymczyk M; Stilgenbauer S; Thieblemont C; Hallek M; Forstpointner R; Pott C; Ribrag V; Doorduijn J; Hiddemann W; Dreyling MH; Unterhalt M
J Clin Oncol; 2014 May; 32(13):1338-46. PubMed ID: 24687837
[TBL] [Abstract][Full Text] [Related]
20. Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.
Spurgeon SE; Till BG; Martin P; Goy AH; Dreyling MP; Gopal AK; LeBlanc M; Leonard JP; Friedberg JW; Baizer L; Little RF; Kahl BS; Smith MR
J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 28040733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
